TO READ THIS STORY - you must have a paid subscription to Technology Review OR you can purchase special archive reading credits here. Choose from these great offers below.

I'm a paid subscriber please
log me in

I want to purchase this article for
only $1.99
(requires login)

I want to purchase five articles for
only $7.99
(requires login)

I want to buy
1 Year TOTAL Access for
only $24.95
(requires login)

Please note: Click here if you are currently a Technology Review print or digital subscriber and do not have access to this article.

Click here if you are an MIT alum and do not have access to this article.

September 2000

The Case for Gene Patents

Drug development cannot thrive without them, argues the CEO of Human Genome Sciences

By William A. Haseltine

The controversy over genes and patents has exposed widespread public confusion over the relevant meaning of both. Apparently, some people mistake patents as ownership rights and see genes only in their broadest possible context as instruments of heredity.

Select from the choices above
to read the entire article.

Customer Service

Magazine Services

•	Subscription FAQ
•	Pay Your Bill
•	Renew Your Subscription
•	Change Your Address
•	Check Your Start/Expire Issue
•	Feedback
•	Buy a Back Issue
•	Permissions/Reprints
•	Cancel Your Subscription
•	Digital Subscription Customer Service